Management of urethral recurrence in patients with Studer ileal neobladder.

Objective: The overall risk of urethral recurrence (UR) of transitional cell carcinoma (TCC) in patients with orthotopic neobladder ranges from 2% to 6%. We are presenting herein our experience in order to evaluate and define the management of these patients, since the cases with urethral recurrence in patients with orthotopic neobladder are very scarce.

Materials And Methods: Five hundred and sixteen radical cystectomies due to TCC were performed at our Centre between January 1990 and February 1998.